SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is trending due to anticipation surrounding a major cross-chain event and positive sentiment regarding its role as the primary liquidity hub for the Base ecosystem. Investors are actively discussing the protocol's revenue growth, the impact of recent tokenomics shifts, and bullish outlooks as they track potential price action ahead of industry conferences.

イロハ (Iroha)

The IROHA crypto project is trending as community members debate its potential to become the next viral meme coin, with supporters citing developer activity and exchange listings while skeptics warn of rug pull risks and label it a scam. Investors are actively comparing the token to established projects, fueling a divided conversation over its legitimacy and long-term viability.

GIGA is a meme token deployed on the Solana blockchain intended to honor the legend Ernest Khalimov the original “Gigachad”, by utilizing the strength of memes and “Chad” energy.  GIGA is a community run project.

GigaChad

GigaChad is capturing community attention as investors debate its long-term potential as a primary meme asset, often highlighting its branding, merchandise initiatives, and perceived cultural reach compared to other sector leaders. While some market participants express frustration over price action and volatility, a dedicated group of proponents continues to emphasize the importance of patient accumulation and community-driven projects during broader market swings.

Maulcoin

Maulcoin is surging in community sentiment as members rally behind its organic growth model and the return of its ticker symbol, with active discussions focusing on smashing resistance levels to reach new market cap milestones. Proponents are highlighting the project's transparent development and community-driven culture as key differentiators from typical pump-and-dump meme coins.

WorldFinancial

WorldFinancial (WLFI) is currently experiencing intense market volatility and negative sentiment as investors scrutinize ongoing investigations into the project's foreign dealings and potential conflicts of interest. The community remains deeply divided, with some traders viewing the current price weakness as a strategic buying opportunity ahead of upcoming industry forums, while others are warning of a long-term decline and potential fraud.

Xiaomi Corp. engages in the design, manufacture and sale of smartphone, hardware and software products. Its business covers power bank, audio, camera and lifestyle. Xiaomi doing business through three business segments-Hardware, E-commerce & New Retail and Internet services. Its products include power bank pro, headphones, in-ear headphones pro, bluetooth headset basic with dock, bluetooth speaker, sphere camera, home security camera, action camera, robot builder, electric scooter, bedside lamp, and body composition scale. The company was founded by Jun Lei, Bin Lin, Wan Qiang Li, Feng Hong, De Liu, Chuan Wang, and Jiang Ji Huang on March 3, 2010 and is headquartered in Beijing, China.

Xiaomi Corporation - ADR

Xiaomi

Xiaomi is trending due to strong demand and sales for its SU7 and YU7 electric vehicles, outperforming some rivals and sparking community excitement about its competitive edge against Tesla in global markets. This positive momentum is further bolstered by a significant share buyback program.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is seeing significant momentum following a strong quarterly earnings report that beat expectations on both earnings and subscriber growth. Investors are actively discussing the impact of new leadership, a major share repurchase program, and the company's strategic expansion in fiber and broadband as it competes to reclaim its position in the telecommunications sector.

Wells Fargo & Co. is a diversified and community-based financial services company, which engages in the provision of banking, insurance, investments, mortgage, and consumer and commercial finance products and services. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment provides banking and credit products across industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment is composed of corporate banking, investment banking, treasury management, commercial real estate lending and servicing, and equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth and Investment Management segment refers to personalized wealth management, brokerage, financial planning, lending, private banking, trust, and fiduciary products and services. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.

Wells Fargo & Co.

Wells Fargo is in focus as investors analyze the bank's latest earnings report, which highlighted solid net interest income and fee growth alongside strategic cost-cutting efforts. The market is also actively weighing the impact of the bank's recently lifted asset cap and its ongoing push into new sectors like options clearing, while some community members remain wary of legal settlements and the bank's historical regulatory challenges.

Select Sector SPDR Trust (The) - State Street Consumer Discretionary Select Sector SPDR ETF

Consumer Discretionary Select Sector SPDR Fund

The Consumer Discretionary Select Sector SPDR Fund ($XLY) is under heavy scrutiny as investors weigh resilient spending against mounting concerns over shifting inflation, potential recessionary indicators, and the impact of broad-based tariff policies on household budgets. Market participants are actively debating the 'K-shaped' recovery and the divergence between luxury performance and the increasing focus on staple necessities, keeping the sector's heavyweights like Amazon and Tesla at the center of the volatility conversation.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending as retail investors and institutions react to a combination of analyst upgrades and a pivotal investor conference where leadership detailed a turnaround strategy. The community is actively debating the company's potential as a buyout candidate, its shift toward insurance-based revenue, and the intensity of the ongoing battle between short sellers and bulls.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The financing includes $5 million in upfront proceeds and $19 million tied to the exercise of warrants.</li><li>Funds will be used to support general operations, business development, and ongoing research and development, the company said.</li><li>Recently, Kiora’s trial to treat retinitis pigmentosa entered the patient dosing phase.</li></ul>Shares of Kiora Pharmaceuticals, Inc. (KPRX) jumped more than 17% in pre-market trading on Tuesday after the company unveiled a $24 million private placement deal, signaling fresh support for its ongoing eye disease treatment pipeline.If the premarket levels hold after the opening bell, <a href="https://stocktwits.com/symbol/KPRX">KPRX shares</a> would trade at their highest levels in more than two months.<h2 class="st-heading-2">KPRX To Receive $5 Million Upfront</h2>The financing includes $5 million in upfront proceeds, with an additional $19 million tied to the potential exercise of milestone-based warrants. The investment was led by Perceptive Advisors and ADAR1 Capital Management.The offering was priced at-the-market, with each share and prefunded warrant sold together at $2.543. These include short-term Tranche A-1 warrants and longer-term Tranche A-2 warrants, both exercisable at $1.94 per share. The Tranche A-2 warrants are valid for up to four years, but their term shortens to 30 days once any of Kiora completes enrolment in a Phase 3 trial.KPRX stock closed at $2.02 on Monday.Kiora said it plans to use the initial funds to support general operations, business development, and ongoing research and development.Recently, Kiora advanced its pipeline with KIO-301 entering patient dosing in the Phase 2 ABACUS-2 trial for retinitis pigmentosa, a rare disease that causes retinal degeneration.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘bullish’ a day earlier, amid ‘extremely high’ message volumes.Chatter was mixed, with one user calling the placement “solid news.”<stembedurl>https://stocktwits.com/The_Assassin/message/649554703</stembedurl>Another user expects the stock to fall below $1 by the end of the week.<stembedurl>https://stocktwits.com/Shortski/message/649556539</stembedurl>Year-to-date, the stock has climbed by around 2%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Last week, Baird maintained AYI’s ‘neutral’ rating but cut price target to $320 from $375. (Representative image: Getty Images)

Why Did KPRX Stock Surge 17% Pre-Market Today?

Kiora Pharmaceuticals (KPRX) - The company announced a $24 million private placement, led by Perceptive Advisors and ADAR1 Capital Management.

Equity

The company announced a $24 million private placement, led by Perceptive Advisors and ADAR1 Capital Management.

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting...

Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know

Kiora Pharmaceuticals (KPRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Kiora Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.

KPRX
Kiora Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest KPRX News

KPRXKiora Pharmaceuticals Inc